Amendment to AgeX Therapeutics, Inc. 2017 Equity Incentive Plan
This amendment updates the AgeX Therapeutics, Inc. 2017 Equity Incentive Plan to increase the total number of shares of common stock available for awards to 8,500,000. It specifies how shares are counted against this limit depending on the type of award granted. The company is required to keep enough shares available to fulfill these awards. The amendment was approved by stockholders on December 7, 2022.
Exhibit 10.1
AMENDMENT TO
AGEX THERAPEUTICS, INC.
2017 EQUITY INCENTIVE PLAN
Approved by Stockholders December 7, 2022
Section 4.1 of the AgeX Therapeutics, Inc. Equity Incentive Plan is amended to read as follows:
4.1 Subject to adjustment in accordance with Section 11, a total of 8,500,000 shares of Common Stock shall be available for the grant of Awards under the Plan. Any shares of Common Stock granted in connection with Options and Stock Appreciation Rights shall be counted against this limit as one share for every one Option or Stock Appreciation Right awarded. Any shares of Common Stock granted in connection with Awards other than Options and Stock Appreciation Rights shall be counted against this limit as two (2) shares of Common Stock for every one (1) share of Common Stock granted in connection with such Award. During the terms of the Awards, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such Awards.
